- Canada's Valeant Pharmaceuticals International Inc is buying rights to AstraZeneca Plc's late-stage experimental psoriasis drug brodalumab after it was dropped by Amgen Inc in May.
CHICAGO - Three out of four U.S. adults have a predicted "heart age" that is older than they are, putting them at increased risk for heart attacks and strokes, government researchers said on Tuesday.
(Reuters Health) - Wrist-worn activity trackers, increasingly popular among consumers and in healthcare research, can vary considerably in their accuracy, a study from Iowa State University suggests.
(Reuters Health) - Between 1998 and 2013, adult bicycling injuries rose sharply in the U.S., largely among riders over age 45, a new study shows.
- Europe's pharmaceuticals industry said on Tuesday it had filed a complaint with the European Commission against a French law promoting the use of Roche's cancer drug Avastin as a cheap eye treatment.
PARIS - Sanofi and Regeneron Pharmaceuticals said on Tuesday that a study into their new cholesterol-lowering drug, Praluent, showed promising results.
- The U.S. Food and Drug Administration on Tuesday issued warning letters to five distributors of pure powdered caffeine, as the federal agency stepped up efforts to curtail ingestion of the stimulant in its pure form.
LONDON - Amgen is launching its injectable cholesterol drug in Europe at around half the U.S. price, in a move likely to stoke controversy about the way Americans end up paying far more than others for new medicines.
SACRAMENTO, Calif. - A controversial bill to allow physician-assisted suicide for terminally ill patients in California comes up for a new round of hearings on Tuesday, after failing in the legislature earlier this summer amid opposition from the Catholic Church.
- The number of U.S. college students smoking marijuana every day or nearly every day is greater than it has been in 35 years, according to a study released on Tuesday.